| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537811 | Pulmonary Pharmacology & Therapeutics | 2018 | 32 Pages |
Abstract
Inhaled nebulised UFH is safe and provides additional clinical benefit for patients with moderate to very severe COPD through effects that are independent of its anticoagulant activity.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Janis K. Shute, Luigino Calzetta, Vittorio Cardaci, Stefania di Toro, Clive P. Page, Mario Cazzola,